* LeMaitre Vascular Inc LMAT.OQ LMAT.O is expected
to show a
rise in quarterly revenue when it reports results on February
23.
* The Burlington Massachusetts-based company is expected to
report a 3.8% increase in revenue to $40.992 million from $39.5
million a year ago, according to the mean estimate from 7
analysts, based on Refinitiv data. The company's guidance on
October 27 2022, for the period ended December 31, was for
revenue of 43.050 million.
* Refinitiv's mean analyst estimate for LeMaitre Vascular
Inc is
for earnings of 26 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for LeMaitre
Vascular
Inc is $60.5, above its last closing price of $49.42.
The company's guidance on October 27 2022 for the period ended
December 31 was for Earnings before Interest and Taxes between
6.6 million and 8.2 million.The company's guidance on October 27
2022 for the period ended December 31 was for gross profit
margin of 65.8%.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2022 0.27 0.28 0.25 Missed -9.9
Jun. 30 2022 0.27 0.27 0.16 Missed -39.6
Mar. 31 2022 0.28 0.28 0.27 Missed -2.6
Dec. 31 2021 0.31 0.31 0.28 Missed -8.6
Sep. 0.33 0.33 0.30 Missed -7.7
30 2021
Jun. 30 2021 0.35 0.34 0.40 Beat 18.2
Mar. 31 2021 0.27 0.27 0.28 Beat 3.1
Dec. 31 2020 0.30 0.29 0.34 Beat 15.9
This summary was machine generated February 22 at 03:03 GMT.
All figures in US dollars unless otherwise stated